» Articles » PMID: 18269318

Glucose-6-phosphate Dehydrogenase Deficiency Enhances Human Coronavirus 229E Infection

Overview
Journal J Infect Dis
Date 2008 Feb 14
PMID 18269318
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

The host cellular environment is a key determinant of pathogen infectivity. Viral gene expression and viral particle production of glucose-6-phosphate dehydrogenase (G6PD)-deficient and G6PD-knockdown cells were much higher than their counterparts when human coronavirus (HCoV) 229E was applied at 0.1 multiplicity of infection. These phenomena were correlated with increased oxidant production. Accordingly, ectopic expression of G6PD in G6PD-deficient cells or addition of antioxidant (such as alpha-lipoic acid) to G6PD-knockdown cells attenuated the increased susceptibility to HCoV 229E infection. All experimental data indicated that oxidative stress in host cells is an important factor in HCoV 229E infectivity.

Citing Articles

Associations between COVID-19 and Glucose-6-Phosphate Dehydrogenase Activity in Brazil.

de Almeida Rodrigues M, Monteiro W, Cardoso de Melo G, Dias A, Sartim M, Xavier M Am J Trop Med Hyg. 2024; 110(6):1191-1197.

PMID: 38593787 PMC: 11154054. DOI: 10.4269/ajtmh.23-0148.


Sex-Specific Total Testosterone and Dehydroepiandrosterone Sulfate Status in Noncritically Ill Hospitalized Patients with Coronavirus Disease 2019: A Cross-Sectional Study.

Banu H, Morshed M, Sultana N, Akter T, Hasanat M, Saleh A Int J Fertil Steril. 2023; 18(1):54-59.

PMID: 38041460 PMC: 10692738. DOI: 10.22074/ijfs.2023.1978415.1407.


Methemoglobinemia in the Setting of G6PD Deficiency and SARS-CoV-2 Infection.

Azizbayeva R, Drennen Z, Solanki R, Keshava V, Bhagavatula R, Sareen M J Community Hosp Intern Med Perspect. 2023; 13(5):61-64.

PMID: 37868669 PMC: 10589043. DOI: 10.55729/2000-9666.1223.


Risk Factors for Glucose 6-Phosphate Dehydrogenase and COVID-19 Disease-A Retrospective Study at a Major Saudi Tertiary Center.

Alotaibi B, Aldali J, Aldali H, Alasiri G, Elsokkary E, Al Mugairi A Viruses. 2023; 15(6).

PMID: 37376524 PMC: 10304955. DOI: 10.3390/v15061224.


G6PD deficiency-does it alter the course of COVID-19 infections?.

Au T, Wisniewski O, Benjamin S, Kubicki T, Dytfeld D, Gil L Ann Hematol. 2023; 102(7):1629-1636.

PMID: 36905446 PMC: 10006571. DOI: 10.1007/s00277-023-05164-y.


References
1.
Ho H, Cheng M, Chiu D . Glucose-6-phosphate dehydrogenase--from oxidative stress to cellular functions and degenerative diseases. Redox Rep. 2007; 12(3):109-18. DOI: 10.1179/135100007X200209. View

2.
Friel H, Lederman H . A nutritional supplement formula for influenza A (H5N1) infection in humans. Med Hypotheses. 2006; 67(3):578-87. DOI: 10.1016/j.mehy.2006.02.040. View

3.
Reinke C, Thomas J, Graves A . Apparent hemolysis in an AIDS patient receiving trimethoprim/sulfamethoxazole: case report and literature review. J Pharm Technol. 1996; 11(6):256-62; quiz 293-5. DOI: 10.1177/875512259501100607. View

4.
Gotsman I, Muszkat M . Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A. J Gastroenterol Hepatol. 2002; 16(11):1239-43. DOI: 10.1046/j.1440-1746.2001.02611.x. View

5.
Cerimele F, Battle T, Lynch R, Frank D, Murad E, Cohen C . Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc Natl Acad Sci U S A. 2004; 102(1):175-9. PMC: 544042. DOI: 10.1073/pnas.0408381102. View